Search
for
Sort by
Research 511–540 of 1000+
- The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth
- Health Benefits, Antioxidant Activity, and Sensory Attributes of Selected Cold-Pressed Oils
- Urotensin II promotes the proliferation and secretion of vascular endothelial growth factor in rat dermal papilla cells by activating the Wnt-β-catenin signaling pathway
- Cholesterol homeostasis in hair follicle keratinocytes is disrupted by impaired ABCA5 activity
- Androgenetic alopecia: Traditional cardiovascular risk factors, metabolic syndrome, and component traits among Nigerian adults
- associations between serum dihydrotestosterone levels, lipid parameters & anthropometric measurements in male patients with type 2 diabetes mellitus
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- CORRELATION BETWEEN ANDROGENIC ALOPECIAAND CORONARY ARTERY DISEASE SEVERITY ON CORONARY ANGIOGRAPHY AMONG YOUNG MALES IN CENTRAL INDIA
- SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- All That Glitters Is Not Gold – The Patient with ‘Excellent’ Weight Loss Following Bariatric Surgery
- A systematic review and meta-analysis on the association between androgenic alopecia and the risk of metabolic syndrome
- Role of Insulin Resistance in Males with Early Androgenetic Alopecia
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- Influence of finasteride treatment on metabolic profile of men with androgenetic alopecia
- The Rotterdam Study: objectives and design update
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Overweight and Obesity in Children and Adolescents
- JAK inhibitors in dermatology: The promise of a new drug class
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- The Rotterdam Study: 2012 objectives and design update
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis